BTIG Downgrades Hologic (HOLX) to Neutral

BTIG downgraded Hologic (NASDAQ: HOLX) from Buy to Neutral on valuation.

Analyst Sean Lavin said, "Several months ago, HOLX traded ~3 points below the group on an earnings basis. Now, the company trades with or above peers and has reached our $26 PT. HOLX trades at ~17.6x NTM EPS vs. peers at 18.2x and due to debt has an EV/Sales of 4.3x vs. an average of 2.9x. While we do not feel shares are overvalued, we do not see valuation metrics that make sense here to offer the 15% upside required for a BUY rating."

For an analyst ratings summary and ratings history on Hologic click here. For more ratings news on Hologic click here.

Shares of Hologic closed at $26.02 yesterday.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Is the global equity rally broadening? UBS weighs in
• Advance Auto Parts (AAP) PT Lowered to $43 at Truist Securities